Signal transduction in alcohol-related diseases.
Apte
Minoti V
MV
Pancreatic Research Group, The University of New South Wales, Sydney, Australia.
Zima
Tomás
T
Dooley
Steven
S
Siegmund
Sören V
SV
Pandol
Stephen J
SJ
Singer
Manfred V
MV
D019973:Alcohol-Related Disorders / Q000175:diagnosis / Q000503:physiopathology* / Q000534:rehabilitation; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D016207:Cytokines / Q000502:physiology; D000431:Ethanol / Q000633:toxicity; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000503:physiopathology; D008104:Liver Cirrhosis, Alcoholic / Q000503:physiopathology / Q000534:rehabilitation; D008108:Liver Diseases, Alcoholic / Q000175:diagnosis / Q000503:physiopathology / Q000534:rehabilitation; D018384:Oxidative Stress / Q000502:physiology; D010179:Pancreas / Q000187:drug effects / Q000503:physiopathology; D019512:Pancreatitis, Alcoholic / Q000175:diagnosis / Q000503:physiopathology / Q000534:rehabilitation; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors / Q000502:physiology
D000975:Antioxidants; D016207:Cytokines; D016212:Transforming Growth Factor beta; D000431:Ethanol